AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06351384 — intervention group
Intervention type: DEVICE
Intervention: miRNA detection test
Description: miRNA sequencing based on Next-Generation Sequencing (NGS) technology
Study NCT05518604 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Counseling with goal of modifying eating behaviors
Description: Dietary counseling will occur virtually a minimum of 4x and as desired by participant in the first year postpartum according to a standard protocol
Study NCT05723588 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: nicotine replacement therapy
Description: All participants will receive nicotine replacement therapy in for the form of 21 mg, 14 mg, and/or 7 mg nicotine patches (based on smoking quantity) and a rescue method such as nicotine lozenge or nicotine gum.
Study NCT05318157 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AIT drops
Description: Once a day
Study NCT05012670 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [14C]-Paxalisib Capsule
Description: Each subject will receive a single dose 15 mg (NMT 3.5 MBq), administered orally in the fasted state with with 240 mL water.
Study NCT05055492 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Take home saliva kits
Description: Saliva kits will be made available at schools for pick up to support symptomatic testing using PCR for students, staff and family members.
Study NCT04796870 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Online Brain and Balance Training Program
Description: The intent of the intervention is to encompass cardiovascular conditioning, cognitive performance and balance performance improvements. To promote cardiovascular conditioning the exercises are structured to keep the participant in motion while maintaining an elevated heart rate using techniques such as squats, marching and upper extremity movements. The video provides adaptations to increase or decrease the challenge based on subject ability. To promote cognitive performance, participants will be asked to complete simple and complex cognitive tasks, such as arithmetic, spatial memory recall and attention while completing the physical exercises. To promote balance performance, the videos include single limb stance and weight shifting tasks. Videos are presented in a progressively challenging manner for all domains.
Study NCT04685161 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgical extrusion
Description: Invasive treatment option for fractured tooth
Study NCT04685161 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Fibre post
Description: Easy approach for treatment
Study NCT05711446 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Double Voiding
Description: Participant will be instructed to void twice.
Study NCT05711446 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Regular Voiding
Description: Participant will void as usual
Study NCT05767879 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Encorafenib + Binimetinib
Description: In the open label phase II study, the combination of BRAF/MEK inhibition with encorafenib/binimetinib in the neo-adjuvant setting will be investigated.~Furthermore, efficacy of adjuvant BRAF/MEK inhibition with encorafenib/binimetinib, for 44 weeks will be evaluated.
Study NCT05145218 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anlotinib Hydrochloride Capsules
Description: Anlotinib Hydrochloride is a multi-target tyrosine kinase inhibitor.
Study NCT05145218 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paclitaxel injection
Description: Paclitaxel is a novel anti-microtubule agent.
Study NCT05145218 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQB2450 injection
Description: TQB2450 is a programmed cell death protein 1 (PD-1) humanized monoclonal antibody.
Study NCT05220267 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Anlotinib plus Sintilimab
Description: Anlotinib was taken orally (10mg mg qd, d1-14, 21 days per cycle).Sintilimab was administered intravenously (200mg once every 3weeks).
Study NCT05439213 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adrenaline 0,33 Mg/mL Solution for Injection
Description: adrenaline dosage
Study NCT05439213 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adrenaline 1 Mg/mL Solution for Injection
Description: adrenaline dosage
Study NCT05318157 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clarityne, Rhinocort and Emedastine Difumarate Eye Drops
Description: The following drugs were permitted as allergy symptoms-relieving medications according to the actual needs in groups: Clarityne, Rhinocort and Emedastine Difumarate Eye Drops, Once a day
Study NCT04161365 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Direct visual urethrotomy
Description: Urethral stricture is treated with urethrotomy under visual control
Study NCT04161365 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Autologous fat grafting
Description: Autologous fat graft is gathered and injected to stricture
Study NCT04101838 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluzone
Description: inactivated seasonal influenza vaccine
Study NCT04764916 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine
Description: Liposomal bupivacaine will be used as adductor canal block
Study NCT04101838 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Flucelvax
Description: inactivated seasonal influenza vaccine
Study NCT04101838 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluzone High-Dose
Description: inactivated seasonal influenza vaccine
Study NCT04101838 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluad
Description: inactivated seasonal influenza vaccine
Study NCT04764916 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine Hydrochloride
Description: This is the facility's standard of care medication for this procedure
Study NCT04764916 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine Hydrochloride
Description: This is the facility's standard of care medication for this procedure
Study NCT04752644 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MVA-mBN294B
Description: MVA-BN-RSV (nominal titre 5 x10\*8 Inf.U per 0.5 mL) as intramuscular injections. Liquid frozen suspension, single dose of 0.5ml.
Study NCT05298267 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Do Not Disturb While Driving
Description: Participants will be asked to turn on Do Not Disturb While Driving on their smartphones.
Study NCT04752644 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: TBS (Placebo) as intramuscular injections (0.5ml)
Study NCT05258188 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Instrument-assisted Soft Tissue Mobilization
Description: Instrument-assisted soft tissue mobilization is used for a mechanical benefit for the therapist providing deeper approach and braces remodeling of connective tissues through dissolution of extravagant fibrosis, while provoking repair and reconstructing forwarded by the recruitment of fibroblast.
Study NCT05258188 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Compressive Myofascial Release Technique
Description: Compressive Myofascial Release Technique is a technique of soft tissue stretching that uses compression and sustained myofascial stretches to create a releasing force in the targeted area
Study NCT05437744 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cyanoacrylate glue
Description: 8 sockets that will be treated by immediate implant placement and sealed by a Cyanoacrylate glue.
Study NCT05437744 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Platelet-rich fibrin (PRF)
Description: 8 sockets that will be treated by immediate implant placement and sealed by PRF.
Study NCT05373888 — intervention group
Intervention type: DEVICE
Intervention: Flexima®/Softima® stoma bags
Description: One piece stoma bags for enterostomates available as:~* Closed (flat and convex)~* Drainable with Roll'Up (flat and convex)~* High flow with tape outlet (flat)
Study NCT06455969 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Goserelin 3.6 MG
Description: Goserelin acetate (Zoladex) is a gonadotropin-releasing hormone agonist (GnRH). GnRH agonists induce a transient increase in sex hormone concentrations, but subsequently inhibit gonadotropin secretion and the production of testosterone in men and estrogen in women. An equilibration period will occur to allow steroid concentrations to reduce.
Study NCT06455969 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multi-Stressor Training
Description: A 4-week physical training program that mimics military training.
Study NCT06455969 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Multi-Stressor Training
Description: A 4-week physical training program that mimics military training.
Study NCT06455969 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Testosterone gel (AndroGel 5g)
Description: Male subjects will be randomly assigned to receive a topical testosterone gel (5g dose).
Study NCT06455969 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Testosterone gel (AndroGel 1.25g)
Description: Male subjects will be randomly assigned to receive a topical testosterone gel (1.25g dose).
Study NCT06455969 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Estradiol / Levonorgestrel Transdermal System [Climara Pro]
Description: Female subjects will be randomly assigned to receive a estrogen/ progesterone patch.
Study NCT06455969 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo Patch
Description: Female subjects will be randomly assigned to receive a placebo patch identical to the Climara Pro patch.
Study NCT00291213 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: levetiracetam
Study NCT00291213 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Study NCT05342038 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: T-02
Description: Stent retriever
Study NCT05194722 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Wysa mobile app
Description: Wysa is a digital mental health intervention (i.e., mobile app) that uses an artificial intelligence based chatbot and text-based conversation with master's level human coach counselors to deliver cognitive behavioral therapy, mindfulness training, and sleep tools. In this study, a customized version of Wysa will be used which is specifically designed for users with coexisting chronic pain. The customized experience includes additional features based on behavioral activation. This version is not currently commercially available.
Study NCT05523271 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: CAD EYE (Computer Aided Diagnosis ----?
Description: CADEYE is a CAD-e system (FUJIFILM) that enables real-time video processing at the same rate as the standard procedure and and allows a real time computer aided detection of polyps with high accuracy.
Study NCT04307615 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Oxygen + continuous positive airway pressure (CPAP)
Description: Oxygen-driven CPAP (7,5 cmH2O): 20 min treatment followed by 10 min rest and assessment
Study NCT04307615 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxygen
Description: Oxygen: 20 min treatment followed by 10 min rest and assessment
Study NCT05860270 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cholecalciferol
Description: Patients in the intervention group will receive oral cholecalciferol 4000U per day.
Study NCT05860270 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients in the control group will receive placebo 2 capsules per day.
Study NCT04800952 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: blood samples and filtered fluid will be collected.
Description: Arterial blood samples will be collected just before the commencement of continuous venovenous haemofiltration (CVVHF) and 1 h after the termination of CVVHF.~Prefilter and post-filter venous blood samples and filtered fluid will be collected 1 and 3 h after the commencement of CVVHF and at the end of CVVHF.
Study NCT05251389 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation
Description: Fecal microbiota transplantation of an ICI responding or Fecal microbiota transplantation from an ICI non-responding donor, in combination with ICI.
Study NCT05702346 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Enhance Physical Activity (EPA)
Description: EPA is eight weeks with four weekly, hour-long parts: virtual group exercises, virtual group discussions, individual PA participation, and individual phone check-ins.
Study NCT05702346 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhance Physical Activity (EPA)
Description: EPA is eight weeks with four weekly, hour-long parts: virtual group exercises, virtual group discussions, individual PA participation, and individual phone check-ins.
Study NCT05638789 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: endoscopic sphincterotomy (EST) versus EST plus endoscopic papillary large balloon dilatation (EPLBD)
Description: EST alone vs EST plus EPLBD in removing common bile duct stone
Study NCT04782206 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: superior hypogastric plexus block
Description: superior hypogastric plexus chemical neurolysis
Study NCT04782206 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: pulsed radiofrequency at S3 root plus superior hypogastric plexus block
Description: pulsed radiofrequency neuromodulation at S3 root plus superior hypogastric plexus chemical neurolysis
Study NCT04287543 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melatonin
Description: 25 mg of melatonin gel at noon and 25 mg of melatonin gel 30 minutes before sleeping for 12 months
Study NCT04287543 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebos
Description: 25 mg of placebo gel at noon and 25 mg of placebo gel 30 minutes before sleeping for 12 months
Study NCT04938297 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab, Lenalidomide, Zanubrutinib
Description: Induction therapy: Rituximab 375 mg / m2, day 1, Zanubrutinib 160 mg bid, orally, Lenalidomide 25mg QD, orally on day 1-21, 28 days as a course of treatment, 8 courses of treatment.
Study NCT04938297 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide, Zanubrutinib
Description: Maintenance therapy: Lenalidomide: 25mg qd (adjusted according to hectogram condition) or Zanubrutinib 160 mg bid. Continuously use for 2 years or until disease progression
Study NCT04938297 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Maintenance therapy: Lenalidomide: 25mg qd (adjusted according to hectogram condition) . Continuously use for 2 years or until disease progression
Study NCT05666557 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: manual erector spinae myofascial realease
Description: The subjects first positioned the third, fourth, and fifth lumbar vertebrae in a relaxed lying position, about 2-3 cm away from the left and right sides (depending on the size of the subjects' muscles). And then in six postures (prone, prone with leg raise, sit straight , slouch sitting, stand straight and slouch standing), MyotonPRO was used to test the above-mentioned 8 points in these position.~Subjects will undergo a pre-mobilization assessment to see if MyotonPRO can detect changes in the erector spinae muscle properties, including changes in muscle tone, stiffness, and elasticity, under different test positions. After physical therapist manual mobilization, MyotonPRO's erector spinae muscle biomechanical data was collected again for data analysis to determine MyotonPRO could objectively quantify changes in erector spinae biomechanical characteristics.
Study NCT05666557 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: self-myofascial release technique
Description: The subjects first positioned the third, fourth, and fifth lumbar vertebrae in a relaxed lying position, about 2-3 cm away from the left and right sides (depending on the size of the subjects' muscles). And then in six postures (prone, prone with leg raise, sit straight , slouch sitting, stand straight and slouch standing), MyotonPRO was used to test the above-mentioned 8 points in these position.~Subjects will undergo a pre-mobilization assessment to see if MyotonPRO can detect changes in the erector spinae muscle properties, including changes in muscle tone, stiffness, and elasticity, under different test positions. After self mobilization by roller, MyotonPRO's erector spinae muscle biomechanical data was collected again for data analysis to determine MyotonPRO could objectively quantify changes in erector spinae biomechanical characteristics.
Study NCT05011591 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Swimming economy
Description: Detailed in arm's section
Study NCT06424496 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Effect of Targeted Health Education Program on Nurses' Awareness About Postpartum Depression
Description: Quazi-Experimental study (pre/post design) to assess the Effect of Targeted Health Education Program on Nurses' Awareness About Postpartum Depression
Study NCT04829084 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pre-post educational intervention
Description: To Increase the attendance of patients with Diabetes Mellitus, for retinal screening at REMEH by providing health education intervention to selected physicians and establishing a referral pathway
Study NCT05468047 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine hydrochloride injection
Description: Individuals will be administered a single dose of sub-anesthetic (0.5-0.75 mg/kg; maximum dose of 60 mg regardless of body weight) ketamine hydrochloride injection intramuscularly as part of a ketamine-assisted therapy experience.
Study NCT06376903 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pilates exercise - pelvic floor exercise - home advices
Description: Group (A) (Study group): It will be consisted of thirty postmenopausal women suffering from mild and moderate stress urinary incontinence, will perform program of pilates exercises, 3 sessions/week (30 minutes a session ) for 12 weeks in addition to Kegel exercises (15min/three times per week/ for 12 weeks) and home care advices.~• Group (B) (Controlled group): It will be consisted of thirty postmenopausal women suffering from mild and moderate stress urinary incontinence, will perform kegel exercises (15min/three times per week/ for 12 weeks) and home care advices as in group (A).
Study NCT05693597 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imtenan Oil
Description: Cold Press Oil
Study NCT05693597 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Baraka Capsules
Description: Soft Gelatin Capsules
Study NCT05620225 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Axon Therapy and CMM
Description: transcutaneous magnetic stimulation (TMS)
Study NCT05620225 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham and CMM
Description: Sham and CMM
Study NCT05312697 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Setrusumab
Description: A fully human anti-sclerostin monoclonal antibody (mAb)
Study NCT04915950 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temanogrel
Description: Participants will receive a single oral dose of temanogrel during the treatment visit.
Study NCT04915950 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will receive a single oral dose of temanogrel matching placebo during the treatment visit.
Study NCT05668611 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Primary Training Phase
Description: A four-day training program taken over the course of two weekends will include materials on RHD and RHD echocardiographic screening using focused artificial intelligence navigational guided echocardiographic acquisition to identify patients who are screen positive or screen negative for RHD. The echo protocol will be limited to the parasternal long axis-view (2D and color Doppler) focusing on mitral and aortic valve morphology and function and a single 2D apical 4 chamber view for auto EF. The curriculum package will include online modules, instructor delivered PowerPoint presentations, and hands on practice on volunteers with and without RHD.
Study NCT05668611 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Primary Assessment Phase
Description: A pre- and post-training test on RHD knowledge and diagnosis will be administered. A rapid competency assessment, including obtaining imaging on volunteers with or without RHD and an online test with pre-recorded cases of RHD, LV dysfunction and Pericardial effusions, will be utilized at the end of the 4-day training sessions. Trainees will be monitored by trained study personnel and at the end of the practicum training, the expert users will blindly review and assess the quality of each study using the standardized scale and competency scorecard provided below. Additionally, they will be asked to pass the knowledge quiz (80% or better). If competency is not achieved, an additional weekend of training can be added.